The Current Ratio as of September 2024 (TTM) for Altamira Therapeutics Ltd. (CYTO) is 1.38

According to Altamira Therapeutics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.38. This represents a change of 62.05% compared to the average of 0.85 of the last 4 quarters.

Altamira Therapeutics Ltd. (CYTO) Historical Current Ratio (quarterly & annually)

How has CYTO Current Ratio performed in the past?

The mean historical Current Ratio of Altamira Therapeutics Ltd. over the last ten years is 3.51. The current 1.38 Current Ratio has changed 3.82% with respect to the historical average. Over the past ten years (40 quarters), CYTO's Current Ratio was at its highest in in the December 2014 quarter at 13.01. The Current Ratio was at its lowest in in the September 2022 quarter at 0.14.

Altamira Therapeutics Ltd. (CYTO) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Altamira Therapeutics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Altamira Therapeutics Ltd. (CYTO) Average Current Ratio

How has CYTO Current Ratio performed in the past?

The current Current Ratio of Altamira Therapeutics Ltd. (CYTO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Altamira Therapeutics Ltd. (CYTO) Current Ratio vs. Peers

How is CYTO’s Current Ratio compared to its peers?

Altamira Therapeutics Ltd.’s Current Ratio is less than Pyxis Oncology, Inc. (9.53), less than Zura Bio Limited (12.57), greater than eFFECTOR Therapeutics, Inc. (1.03), less than Elevation Oncology, Inc. (41.10), less than Immix Biopharma, Inc. (7.00), less than Enveric Biosciences, Inc. (7.37), less than Palisade Bio, Inc. (4.31), less than CNS Pharmaceuticals, Inc. (0), greater than ZyVersa Therapeutics, Inc. (0.31), greater than VectivBio Holding AG (0.06), less than AVROBIO, Inc. (9.14), less than null (26.17),

Build a custom stock screener for Altamira Therapeutics Ltd. (CYTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altamira Therapeutics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Altamira Therapeutics Ltd. (CYTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Altamira Therapeutics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.